FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Innovations in Care

We provide programs and services that transform the lives of people affected by neuromuscular disease.

Daily Living: Practical Solutions for Accessing Equipment and Assistive Devices

December 18th, 2025
1:00pm - 2:00pm EST
Live, Virtual Webinar

Join MDA for an informative webinar focused on practical solutions for accessing equipment and assistive devices. Whether you're a patient, caregiver, or advocate, this webinar will offer valuable insights, resources, and support.

What We’ll Cover:

  • The types of equipment and assistive devices commonly used by individuals living with neuromuscular disease
  • The process of obtaining durable medical equipment (DME)
  • Roles of care center staff in obtaining equipment
  • Live Q&A with the presenter(s)

Register

Meet Our Presenter(s):
Molly Stark, PT DPT

Molly Stark is a physical therapist and clinical evaluator at the Greg Marzolf Jr. Muscular Dystrophy Center at the University of Minnesota. She received her Bachelor of Science and Doctor of Physical Therapy degrees from the University of Wisconsin – La Crosse. She has been a physical therapist for 12 years, and she has 10 years of experience working with children and adults with neuromuscular disease. Molly is also a clinical evaluator and is involved in multiple clinical trials and research studies. Molly is passionate about enhancing therapeutic outcomes and quality of life for those living with neuromuscular disease.

Not available to join live on December 18th ? Register to receive an email when the webinar is available to view on-demand.

If you have questions about this webinar or other MDA programs, please contact the MDA Resource Center at 1-833-ASK-MDA1 (275-6321) or ResourceCenter@mdausa.org.

Faculty: 
Molly Stark, PT DPT
Molly Stark, PT DPT
Physical Therapist and Clinical Evaluator

Greg Marzolf Jr. Muscular Dystrophy Center at the University of Minnesota


Thank you to our supporters:

AmgenEdgewise TherapeuticsMitsubishi Tanabe Pharma, America